Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allantoin is a naturally occurring *chemical compound* (C₄H₆N₄O₃), best known as a *metabolite* in the catabolism of purines, specifically as the oxidation product of uric acid in most mammals but not in humans. It is found widely in nature, particularly in plants like comfrey, and is present in high concentrations in the allantois of developing embryos, from which its name is derived. In medicine and consumer care, allantoin is commonly used as a skin protectant, moisturizer (humectant), and wound-healing enhancer. It softens keratin, promotes cell proliferation, facilitates tissue repair, and has anti-irritant and mild anti-inflammatory properties. Allantoin is widely incorporated in creams, lotions, shampoos, toothpastes, and oral care products. Clinically, allantoin is occasionally used as a biomarker for oxidative stress. It is not the target of pharmacological agents and does not act as a receptor, enzyme, or transporter[2][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allantoin.